The American Society of Tropical Medicine and Hygiene has waived the Open Access fee for this article due to the ongoing COVID-19 pandemic.
Kloc M, Ghobrial RM, Lipińska-Opałka A, Wawrzyniak A, Zdanowski R, Kalicki B, Kubiak JZ, 2021. Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients. Cell Immunol 360: 104259.
Szeto B, Zucker JE, LaSota ED, Rubin MR, Walker MD, Yin MT, Cohen A, 2021. Vitamin D status and COVID-19 clinical outcomes in hospitalized patients. Endocr Res 46: 66–73.
Abrishami A, Dalili N, Torbati PM, Asgari R, Arab-Ahmadi M, Behnam B, Sanei-Taheri M, 2021. Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study. Eur J Nutr 60: 2249–2257.
World Health Organization , 2004. Appropriate Body-mass Index for Asian Populations and Its Implications for Policy and Intervention Strategies. Geneva, Switzerland: WHO. Available at: https://www.who.int/nutrition/publications/bmi_asia_strategies.pdf. Accessed March 11, 2021.
Malek Mahdavi A, 2020. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: implications for a potential treatment for COVID-19. Rev Med Virol 30: e2119.
Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A, 2021. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res 292: 198235.
Yisak H, Ewunetei A, Kefale B, Mamuye M, Teshome F, Ambaw B, Yideg Yitbarek G, 2021. Effects of vitamin D on COVID-19 infection and prognosis: a systematic review. Risk Manag Healthc Policy 14: 31–38.
Waldron JL, Ashby HL, Cornes MP, Bechervaise J, Razavi C, Thomas OL, Chugh S, Deshpande S, Ford C, Gama R, 2013. Vitamin D: a negative acute phase reactant. J Clin Pathol 66: 620–622.
Weir EK, Thenappan T, Bhargava M, Chen Y, 2020. Does vitamin D deficiency increase the severity of COVID-19? Clin Med (Lond) 20: e107–e108.
Murai IH et al.2021. Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial. JAMA 325: 1053–1060.
Güven M, Gültekin H, 2021. The effect of high-dose parenteral vitamin D3 on COVID-19-related inhospital mortality in critical COVID-19 patients during intensive care unit admission: an observational cohort study. Eur J Clin Nutr 75: 1383–1388.
Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF, 2020. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One 15: e0239252.
Baktash V, Hosack T, Patel N, Shah S, Kandiah P, Van den Abbeele K, Mandal AKJ, Missouris CG, 2021. Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J 97: 442–447.